Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Pharmacol Exp Ther
2020 Feb 01;3722:148-156. doi: 10.1124/jpet.119.263350.
Show Gene links
Show Anatomy links
M-Channel Activation Contributes to the Anticonvulsant Action of the Ketone Body β-Hydroxybutyrate.
Manville RW
,
Papanikolaou M
,
Abbott GW
.
???displayArticle.abstract???
Ketogenic diets are effective therapies for refractory epilepsy, yet the underlying mechanisms are incompletely understood. The anticonvulsant efficacy of ketogenic diets correlates positively to the serum concentration of β-hydroxybutyrate (BHB), the primary ketone body generated by ketosis. Voltage-gated potassium channels generated by KCNQ2-5 subunits, especially KCNQ2/3 heteromers, generate the M-current, a therapeutic target for synthetic anticonvulsants. Here, we report that BHB directly activates KCNQ2/3 channels (EC50 = 0.7 µM), via a highly conserved S5 tryptophan (W265) on KCNQ3. BHB was also acutely effective as an anticonvulsant in the pentylene tetrazole (PTZ) seizure assay in mice. Strikingly, coadministration of γ-amino-β-hydroxybutyric acid, a high-affinity KCNQ2/3 partial agonist that also acts via KCNQ3-W265, similarly reduced the efficacy of BHB in KCNQ2/3 channel activation in vitro and in the PTZ seizure assay in vivo. Our results uncover a novel, unexpected molecular basis for anticonvulsant effects of the major ketone body induced by ketosis. SIGNIFICANCE STATEMENT: Ketogenic diets are used to treat refractory epilepsy but the therapeutic mechanism is not fully understood. Here, we show that clinically relevant concentrations of β-hydroxybutyrate, the primary ketone body generated during ketogenesis, activates KCNQ2/3 potassium channels by binding to a specific site on KCNQ3, an effect known to reduce neuronal excitability. We provide evidence using a mouse chemoconvulsant model that KCNQ2/3 activation contributes to the antiepileptic action of β-hydroxybutyrate.
Abbott,
KCNQ1, KCNE2, and Na+-coupled solute transporters form reciprocally regulating complexes that affect neuronal excitability.
2014, Pubmed,
Xenbase
Abbott,
KCNQ1, KCNE2, and Na+-coupled solute transporters form reciprocally regulating complexes that affect neuronal excitability.
2014,
Pubmed
,
Xenbase
Belelli,
Extrasynaptic GABAA receptors: form, pharmacology, and function.
2009,
Pubmed
Bergqvist,
Selenium deficiency associated with cardiomyopathy: a complication of the ketogenic diet.
2003,
Pubmed
Biervert,
A potassium channel mutation in neonatal human epilepsy.
1998,
Pubmed
,
Xenbase
Boison,
New insights into the mechanisms of the ketogenic diet.
2017,
Pubmed
Brown,
Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone.
1980,
Pubmed
Böhme,
Four amino acids in the alpha subunits determine the gamma-aminobutyric acid sensitivities of GABAA receptor subtypes.
2004,
Pubmed
Chemello,
[Effect of gamma-amino-beta-hydroxybutyric acid (GABHB) on experimentally-induced epileptic activity].
1980,
Pubmed
Falco-Walter,
The new definition and classification of seizures and epilepsy.
2018,
Pubmed
Freeman,
The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children.
1998,
Pubmed
Freiman,
K(+)-evoked [(3)H]-norepinephrine release in human brain slices from epileptic and non-epileptic patients is differentially modulated by gabapentin and pinacidil.
2006,
Pubmed
García-Flores,
gamma-Amino-beta-hydroxybutyric acid as add-on therapy in adult patients with severe focal epilepsy.
1997,
Pubmed
Gilbert,
The ketogenic diet: seizure control correlates better with serum beta-hydroxybutyrate than with urine ketones.
2000,
Pubmed
Grosdidier,
SwissDock, a protein-small molecule docking web service based on EADock DSS.
2011,
Pubmed
Grosdidier,
Fast docking using the CHARMM force field with EADock DSS.
2011,
Pubmed
Hahn,
Disordered mineral metabolism produced by ketogenic diet therapy.
1979,
Pubmed
Hartman,
Intermittent fasting: a "new" historical strategy for controlling seizures?
2013,
Pubmed
Hassan,
Ketogenic diet in the treatment of refractory epilepsy in childhood.
1999,
Pubmed
Hrynevich,
β-Hydroxybutyrate supports synaptic vesicle cycling but reduces endocytosis and exocytosis in rat brain synaptosomes.
2016,
Pubmed
Johansson,
Defining and searching for structural motifs using DeepView/Swiss-PdbViewer.
2012,
Pubmed
Karim,
Potency of GABA at human recombinant GABA(A) receptors expressed in Xenopus oocytes: a mini review.
2013,
Pubmed
,
Xenbase
Kash,
Structural elements involved in activation of the gamma-aminobutyric acid type A (GABAA) receptor.
2004,
Pubmed
Kim,
Atomic basis for therapeutic activation of neuronal potassium channels.
2015,
Pubmed
,
Xenbase
Kinsman,
Efficacy of the ketogenic diet for intractable seizure disorders: review of 58 cases.
1992,
Pubmed
LaManna,
Ketones suppress brain glucose consumption.
2009,
Pubmed
Lee,
Channel-mediated tonic GABA release from glia.
2010,
Pubmed
Main,
Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine.
2000,
Pubmed
,
Xenbase
Manville,
Direct neurotransmitter activation of voltage-gated potassium channels.
2018,
Pubmed
,
Xenbase
Martire,
M channels containing KCNQ2 subunits modulate norepinephrine, aspartate, and GABA release from hippocampal nerve terminals.
2004,
Pubmed
Morris,
Cerebral ketone body metabolism.
2005,
Pubmed
Nordli,
The ketogenic diet, four score and seven years later.
2009,
Pubmed
Pan,
Human brain beta-hydroxybutyrate and lactate increase in fasting-induced ketosis.
2000,
Pubmed
Payne,
The ketogenic and related diets in adolescents and adults--a review.
2011,
Pubmed
Peretz,
Pre- and postsynaptic activation of M-channels by a novel opener dampens neuronal firing and transmitter release.
2007,
Pubmed
Rahman,
The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages.
2014,
Pubmed
Rundfeldt,
Characterization of the K+ channel opening effect of the anticonvulsant retigabine in PC12 cells.
1999,
Pubmed
Santhakumar,
Contributions of the GABAA receptor alpha6 subunit to phasic and tonic inhibition revealed by a naturally occurring polymorphism in the alpha6 gene.
2006,
Pubmed
,
Xenbase
Schenzer,
Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine.
2005,
Pubmed
,
Xenbase
Schroeder,
Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy.
1998,
Pubmed
,
Xenbase
Scimemi,
Plasticity of GABA transporters: an unconventional route to shape inhibitory synaptic transmission.
2014,
Pubmed
Shorvon,
The epidemiology and treatment of chronic and refractory epilepsy.
1996,
Pubmed
Singh,
A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns.
1998,
Pubmed
Singh,
Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization.
2008,
Pubmed
Singh,
KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum.
2003,
Pubmed
,
Xenbase
Soh,
Conditional deletions of epilepsy-associated KCNQ2 and KCNQ3 channels from cerebral cortex cause differential effects on neuronal excitability.
2014,
Pubmed
Sun,
Cryo-EM Structure of a KCNQ1/CaM Complex Reveals Insights into Congenital Long QT Syndrome.
2017,
Pubmed
,
Xenbase
Tallian,
Role of the ketogenic diet in children with intractable seizures.
1998,
Pubmed
Taub,
Risk of seizure recurrence after achieving initial seizure freedom on the ketogenic diet.
2014,
Pubmed
Valente-Silva,
Ketone bodies effectively compete with glucose for neuronal acetyl-CoA generation in rat hippocampal slices.
2015,
Pubmed
Wang,
[The effect of valsartan and fluvastatin on the connective tissue growth factor expression in experimental diabetic cardiomyopathy].
2009,
Pubmed
Wang,
KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel.
1998,
Pubmed
,
Xenbase
Watanabe,
Disruption of the epilepsy KCNQ2 gene results in neural hyperexcitability.
2000,
Pubmed
Wickenden,
Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels.
2000,
Pubmed
Yang,
Anesthetic properties of the ketone bodies beta-hydroxybutyric acid and acetone.
2007,
Pubmed
,
Xenbase
Zaika,
Determinants within the turret and pore-loop domains of KCNQ3 K+ channels governing functional activity.
2008,
Pubmed
Zhang,
Decreased carbon shunting from glucose toward oxidative metabolism in diet-induced ketotic rat brain.
2015,
Pubmed
